DEFICIÊNCIA DE FERRO NA PRIMEIRA INFÂNCIA: UMA REVISÃO SISTEMÁTICA
LUMEN ET VIRTUS · 11.08.2026 · 17 (63) · e14013
DOI: 10.56238/levv17n63-022 ↗Kurz gefasst
Fachartikel in der Zeitschrift LUMEN ET VIRTUS, online erschienen am 11.08.2026. Verfasst von Janaína Costa Canarim und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Iron deficiency is a common nutritional disorder during infancy and the preschool years, when rapid growth, limited iron reserves, dietary transitions, prematurity, inflammation, and socioeconomic vulnerability may converge. Depletion of iron stores can precede anemia and may affect erythropoiesis, motor development, cognition, behavior, sleep, and neural maturation during sensitive developmental periods.
Objective
The main objective was to systematically synthesize recent evidence on the epidemiology, determinants, diagnosis, developmental consequences, prevention, and treatment of iron deficiency in early childhood. Secondary objectives were to evaluate high-risk populations, compare diagnostic biomarkers, examine nutritional and perinatal determinants, assess developmental outcomes, and summarize evidence regarding supplementation and therapeutic formulations.
Methods
PubMed, Scopus, Web of Science, the Cochrane Library, Latin American and Caribbean Health Sciences Literature, ClinicalTrials.gov, and the International Clinical Trials Registry Platform were searched for recent studies involving children from birth to five years of age. Observational studies, diagnostic investigations, clinical trials, and longitudinal cohorts evaluating iron status, iron deficiency, or iron deficiency anemia were eligible. Risk of bias was assessed according to study design, and certainty of evidence was interpreted using the Grading of Recommendations Assessment, Development and Evaluation framework. Results and Discussion: Twenty studies were included in the qualitative synthesis. Iron deficiency remained prevalent among children exposed to prematurity, rapid growth, inadequate complementary feeding, low dietary diversity, infection, stunting, and socioeconomic deprivation. Hemoglobin alone consistently underestimated early deficiency, whereas serum ferritin interpreted with inflammatory markers, transferrin saturation, soluble transferrin receptor, and reticulocyte hemoglobin improved detection. Chronic deficiency was associated with poorer cognitive, motor, behavioral, and selected neurophysiological outcomes, although developmental findings varied across populations. Oral iron generally improved hematologic indices, but evidence regarding complete developmental recovery, optimal dosing, formulation superiority, and universal supplementation remained heterogeneous.
Conclusion
Early childhood iron deficiency requires prevention before anemia develops, risk-based surveillance, inflammation-adjusted laboratory interpretation, and timely nutritional or pharmacological treatment. Premature infants and children with restricted diets, growth impairment, chronic infection, or adverse socioeconomic conditions require particularly close follow-up. Clinical management should integrate hematologic recovery with dietary assessment, developmental surveillance, and investigation of the underlying cause.
Zitieren
APA
Canarim, J. C., Macedo, C. D., Martins, F. F. S., Capalti, M. P. D. S., & Gaspar, H. A. (2026). DEFICIÊNCIA DE FERRO NA PRIMEIRA INFÂNCIA: UMA REVISÃO SISTEMÁTICA. LUMEN ET VIRTUS, 17(63), e14013. https://doi.org/10.56238/levv17n63-022
Vancouver
Canarim JC, Macedo CD, Martins FFS, Capalti MPDS, Gaspar HA. DEFICIÊNCIA DE FERRO NA PRIMEIRA INFÂNCIA: UMA REVISÃO SISTEMÁTICA. LUMEN ET VIRTUS. 2026;17(63):e14013. doi:10.56238/levv17n63-022
BibTeX
@article{Canarim2026,
author = {Canarim, Janaína Costa and Macedo, Camila Diana and Martins, Filipe Ferreira Santos and Capalti, Mariana Poiani dos Santos and Gaspar, Helena Abbud},
title = {DEFICIÊNCIA DE FERRO NA PRIMEIRA INFÂNCIA: UMA REVISÃO SISTEMÁTICA},
journal = {LUMEN ET VIRTUS},
year = {2026},
volume = {17},
number = {63},
pages = {e14013},
doi = {10.56238/levv17n63-022}
}
EUVIMED